Bse Dollex 30

In terms of the provisions of Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Listing Regulations’), as amended from time to time, Poddar Pigments has informed that the Board of Directors of the Company in its meeting held today at 12.05 pm and concluded at 2.00 pm, have considered the following: (a) Approved the Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2026 along with the Statement of Assets & Liabilities and Cash Flow Statement for the financial year ended 31st March, 2026. The said Audited Financial Results for the quarter and year ended 31st March, 2026 along with the Statement of Assets & Liabilities and Cash Flow Statement for the financial year ended 31st March, 2026 and the Auditor’s Report thereon issued by K.N. Gutgutia & Co., Chartered Accountants, Statutory Auditors of the Company with unmodified opinion are attached as Annexure-I. (b) Recommended Final Dividend at the rate of 40% i.e. Rs. 4/- per equity share of Rs. 10/- each for the financial year ended 31st March, 2026, subject to the approval of shareholders in the ensuing 35th Annual General Meeting. (c) Fixed the Book Closure date 7 days before the date of the 35th Annual General Meeting.

Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (referred as the ‘Listing Regulations’) D. P. Abhushan has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, May 21, 2026, at the corporate office of the Company situated at 19, Chandani Chowk, Ratlam – 457001, Madhya Pradesh, 1. to consider, approve & take on record the Audited Financial Results of the Company for the quarter and year ended on March 31, 2026 as per Regulation 33 of the Listing Regulation and 2. to conduct any other businesses as may be decided by the Board. Further, pursuant to provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended and the Company’s Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the trading window for dealing in securities of the Company is already closed from April 1, 2026 and the same will be re-opened after 48 hours of the declaration and publication of Audited Financial Results for the quarter and year ended March 31, 2026.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mangalam Drugs and Organics has informed that it enclosed copies of newspaper advertisement published in Financial Express and Loksatta, both in which Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended March 31, 2026 have been published. The aforesaid results have been approved by the Board of Directors in its meeting held on Thursday, May 14, 2026.

The above information is a part of company’s filings submitted to BSE.

Mangal Electrical Industries has informed that the equity shares of the Company have been listed on BSE and National Stock Exchange of India with effect from August 28, 2025. Accordingly, pursuant to Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, a Statement confirming no deviation or variation in the utilization of proceeds raised through issuance of equity shares by way of Initial Public offer (‘IPO’) for quarter ended March 31, 2026 is enclosed as Annexure I, in the format as prescribed. 

The above information is a part of company’s filings submitted to BSE.